{"abstract": "Closing a $52 million Series D round of financing, Boston\u2019s Surface Logix has raised $20 million to help fund clinical development of its small molecule drug candidates. The round was fed by existing investors such as Venrock Associates, Arch Venture Partners, CW Group, HBM BioVentures, and Unilever Technology Partners. ", "web_url": "https://dealbook.nytimes.com/2007/04/04/surface-logix-gets-20-million-in-series-d-round/", "snippet": "", "lead_paragraph": "Closing a $52 million Series D round of financing, Boston\u2019s Surface Logix has raised $20 million to help fund clinical development of its small molecule drug candidates. The round was fed by existing investors such as Venrock Associates, Arch Venture Partners, CW Group, HBM BioVentures, and Unilever Technology Partners. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Surface Logix Gets $20 Million in Series D Round", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2007-04-04T11:39:39+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/09d0dafa-5afd-5c39-a418-040a0e9963f4", "word_count": 109, "uri": "nyt://article/09d0dafa-5afd-5c39-a418-040a0e9963f4"}